Lina Dai

Lina Dai is an accomplished marketing professional with extensive experience in the biopharmaceutical industry, currently serving as a Senior Marketing Manager at Amgen since June 2016, specializing in oncology and inflammation products. Key responsibilities include brand strategy, budget management, and patient access program management for Blincyto and Otezla, along with significant contributions to Enbrel's marketing initiatives. Lina's career also includes roles at Duke University Health System and various internships that advanced expertise in strategic marketing and product strategy. Lina holds an MBA in Health Care Administration from Duke University's Fuqua School of Business and dual bachelor's degrees in English and Business Management from Beijing Foreign Studies University.